Back to Journals » International Journal of Nanomedicine » Volume 7

Heparin nanomodification improves biocompatibility and biomechanical stability of decellularized vascular scaffolds

Authors Tao Y, Tiehui Hu, Zhongshi Wu, Tang, Hu Y, Tan, Chunlin Wu

Received 17 August 2012

Accepted for publication 22 October 2012

Published 26 November 2012 Volume 2012:7 Pages 5847—5858


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Yunming Tao,1,2 Tiehui Hu,1 Zhongshi Wu,1 Hao Tang,1 Yerong Hu,1 Qi Tan,1 Chunlin Wu1

1Department of Thoracic and Cardiovascular Surgery, Second Xiangya Hospital of Central South University, Changsha; 2Department of Thoracic and Cardiovascular Surgery, Ji'an Central People’s Hospital, Ji'an, Jiangxi Province, People's Republic of China

Abstract: Biocompatibility and biomechanical stability are two of the main obstacles limiting the effectiveness of vascular scaffolds. To improve the biomechanical stability and biocompatibility of these scaffolds, we created a heparin-nanomodified acellular bovine jugular vein scaffold by alternating linkage of heparin and dihydroxy-iron via self-assembly. Features of the scaffold were evaluated in vitro and in vivo. Heparin was firmly linked to and formed nanoscale coatings around the fibers of the scaffold, and the amount of heparin linked was about 808 ± 86 µg/cm2 (101 ± 11 USP/cm2) per assembly cycle. The scaffolds showed significantly strengthened biomechanical stability with sustained release of heparin for several weeks in vitro. Importantly, the modified scaffolds showed significantly reduced platelet adhesion, stimulated proliferation of endothelial cells in vitro, and reduced calcification in a subcutaneous implantation rat model in vivo. Heparin nanomodification improves the biocompatibility and biomechanical stability of vascular scaffolds.

Keywords: scaffolds, nanomodification, heparin, sustained release, biomechanical stability, biocompatibility

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.